Farhad Jeddi
Ardabil University of Medical Sciences
39 Papers
119 Citations
Farhad Jeddi is an academic researcher from Ardabil University of Medical Sciences. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 10, co-authored 25 publications. Previous affiliations of Farhad Jeddi include University of Tabriz & Tabriz University of Medical Sciences.
Chat about Author
Papers
Biomimetic synthesis of silver nanoparticles using Matricaria chamomilla extract and their potential anticancer activity against human lung cancer cells.
Mehdi Dadashpour,Akram Firouzi-Amandi,Mohammad Pourhassan-Moghaddam,Mohammad Jafar Maleki,Narges Soozangar,Farhad Jeddi,Mohammad Nouri,Nosratollah Zarghami,Younes Pilehvar-Soltanahmadi +8 more
TL;DR: In vitro cytotoxicity assay using MTT revealed that the biosynthesized AgNPs exhibited a dose- and time- dependent cytotoxic effect against A549 lung cancer cells, and the apoptotic effects of the AgNBP were demonstrated using DAPI staining, real-time PCR and flow cytometry.
137
An update of Nrf2 activators and inhibitors in cancer prevention/promotion
TL;DR: In this paper , a review of NF-E2-related factor 2 (Nrf2) inducers and inhibitors and their chemopreventive and/or anticancer activities is presented.
Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance.
TL;DR: Inhibition of the permanent Nrf2 activation, especially in combination with chemotherapeutics against cancer, may be considered as an important strategy to inhibit tumor growth and overcome chemoresistance.
85
Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer.
Farhad Jeddi,Narges Soozangar,Mohammad Reza Sadeghi,Mohammad Hossein Somi,Masoud Shirmohamadi,Amir-Taher Eftekhar-Sadat,Nasser Samadi +6 more
TL;DR: It is suggested that therapeutic inhibition of Nrf2 expression can improve the efficacy of chemotherapeutic agents for GC patients by down regulation of P-gp expression.
64